uniQure
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade uniQure 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About QURE
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems.
CEOMatthew C. Kapusta
CEOMatthew C. Kapusta
Employees209
Employees209
HeadquartersAmsterdam, Noord-Holland
HeadquartersAmsterdam, Noord-Holland
Founded2012
Founded2012
Employees209
Employees209
QURE Key Statistics
Market cap1.47B
Market cap1.47B
Price-Earnings ratio-5.46
Price-Earnings ratio-5.46
Dividend yield—
Dividend yield—
Average volume3.36M
Average volume3.36M
High today$25.75
High today$25.75
Low today$22.80
Low today$22.80
Open price$23.15
Open price$23.15
Volume3.10M
Volume3.10M
52 Week high$71.50
52 Week high$71.50
52 Week low$7.76
52 Week low$7.76
Stock Snapshot
As of today, uniQure(QURE) shares are valued at $24.20. The company's market cap stands at 1.47B, with a P/E ratio of -5.46.
During the trading session on 2025-12-19, uniQure(QURE) shares reached a daily high of $25.75 and a low of $22.80. At a current price of $24.20, the stock is +6.1% higher than the low and still -6.0% under the high.
Trading activity shows a volume of 3.1M, compared to an average daily volume of 3.36M.
Over the past 52 weeks, uniQure(QURE) stock has traded between a high of $71.50 and a low of $7.76.
Over the past 52 weeks, uniQure(QURE) stock has traded between a high of $71.50 and a low of $7.76.
Analyst ratings
86%
of 14 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own QURE. This list is generated using Robinhood data, and it’s not a recommendation.